Cargando…
Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of age-related dementia. Despite decades of research, the etiology and pathogenesis of AD are not well understood. Brain glucose hypometabolism has long been recognized as a prominent anomaly that occurs in the preclinical stage of AD. Recent studies...
Autores principales: | Zhang, Xin, Alshakhshir, Nadine, Zhao, Liqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113697/ https://www.ncbi.nlm.nih.gov/pubmed/33994936 http://dx.doi.org/10.3389/fnins.2021.662242 |
Ejemplares similares
-
Sialometabolism in Brain Health and Alzheimer’s Disease
por: Rawal, Punam, et al.
Publicado: (2021) -
Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer’s Disease
por: Zhang, Xin, et al.
Publicado: (2023) -
Suppression of hnRNP A1 binding to HK1 RNA leads to glycolytic dysfunction in Alzheimer’s disease models
por: Ji, Xin-Hao, et al.
Publicado: (2023) -
High Resolution Measurement of the Glycolytic Rate
por: Bittner, Carla X., et al.
Publicado: (2010) -
Classification of Alzheimer’s Disease Based on Deep Learning of Brain Structural and Metabolic Data
por: Wang, Huiquan, et al.
Publicado: (2022)